Key result
Excessive weight gain drives arterial hypertension via sympathetic overactivity and RAAS activation, though no single pharmacological class is currently proven superior for its management.
Population
Patients with obesity-hypertension
Design
Review
Authors
Loading...
Prioritizes lifestyle interventions in obesity-hypertension; leaves open identification of optimal pharmacotherapy.
This review highlights the pathophysiological mechanisms linking obesity and hypertension, noting that while lifestyle changes are effective, no single pharmacological class is proven superior for treatment.
Francischetti et al. (2007) conducted a review in Obesity-hypertension. Excessive weight gain drives arterial hypertension via sympathetic overactivity and RAAS activation, though no single pharmacological class is currently proven superior for its management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: